Cited by 272Cystic Fibrosis Research AdvancesHealth Education and ValidationHealth Systems, Economic Evaluations, Quality of Life

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis

Open access

Gee, L·2000·Thorax

DOI 10.1136/thorax.55.11.946PMC PMC1745639

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Health related quality of life (HRQoL) measurement is important in determining the impact of disease on daily functioning and subsequently informing interventions. In cystic fibrosis (CF) generic HRQoL measures have been employed but these may not be sufficiently specific. The aim of the current work was to develop and validate a disease specific HRQoL measure for adults and adolescents with cystic fibrosis. METHODS: Areas of concern to adults and adolescents with CF were identified by unstructured interviews, self-administered questionnaires, consultation with multidisciplinary specialist staff, a review of the relevant literature, and examination of other HRQoL measures. Items for the questionnaire were generated on the basis of this process. Continued evaluation and development of the Cystic Fibrosis Quality of Life (CFQoL) questionnaire was undertaken by a process of statistical analysis and continued feedback from patients. The full testing and validation of the CFQoL questionnaire took place over four phases: (1) initial item generation and testing of a preliminary questionnaire, (2) testing and validation of the second version of the questionnaire, (3) test-retest reliability of a third and final version of the questionnaire, and (4) sensitivity testing of the final version of the questionnaire. RESULTS: Nine domains of functioning were identified using principal components analysis with varimax rotation. Internal reliability of the identified domains was demonstrated using Cronbach alpha coefficients (range 0.72-0.92) and item to total domain score correlations. Concurrent validity (range r = 0.64-0.74), discriminatory ability between different levels of disease severity, sensitivity across transient changes in health (effect size range, moderate d = 0.56 to large d = 1.95), and test-retest reliability (r = 0.74-0.96) were also found to be robust. CONCLUSIONS: The CFQoL questionnaire is a fully validated disease specific measure consisting of 52 items across nine domains of functioning which have been identified by, and are of importance to, adolescents and adults with cystic fibrosis. This measure will be useful in clinical trials and longitudinal studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/thorax.55.11.946

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Validating the SF-36 health survey questionnaire: new outcome measure for primary care.
Brazier, J. E., Harper, R., Jones, N. M., O’Cathain, A., Thomas, K. J., Usherwood, T. P., & Westlake, L. (1992) · BMJ · doi:10.1136/bmj.305.6846.160 · Cited by 4,660
Gender variations in clinical pain experience
Unruh, A. M. (1996) · Pain · doi:10.1016/0304-3959(95)00214-6 · Cited by 1,550
Handbook of multivariate experimental psychology
Nesselroade, J., & Cattell, R. (1968) · Springer eBooks · doi:10.1007/978-1-4613-0893-5 · Cited by 1,351
The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?
Garratt, A., Ruta, D. A., Abdalla, M., Buckingham, J. K., & Russell, I. T. (1993) · BMJ · doi:10.1136/bmj.306.6890.1440 · Cited by 1,153
The Meaning and Strategic Use of Factor Analysis
Cattell, R. B. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0893-5_4 · Cited by 442
The Quality of Well-Being Scale: Applications in AIDS, Cystic Fibrosis, and Arthritis
Kaplan, R. M., Anderson, J. P., Wu, A. W., Mathews, W. C., Kozin, F., & Orenstein, D. (1989) · Medical Care · doi:10.1097/00005650-198903001-00003 · Cited by 344
Gender Differences in the Comparison of Self-Reported Disability and Performance Measures
Merrill, S., Seeman, T. E., Kasl, S. V., & Berkman, L. F. (1997) · The Journals of Gerontology Series A · doi:10.1093/gerona/52a.1.m19 · Cited by 290
The Quality of Well-being in Cystic Fibrosis
Orenstein, D. M., Nixon, P. A., Ross, E. A., & Kaplan, R. M. (1989) · CHEST Journal · doi:10.1378/chest.95.2.344 · Cited by 177
A two way view of gender bias in medicine
Ruiz, M. T., & Verbrugge, L. M. (1997) · Journal of Epidemiology and Community Health · doi:10.1136/jech.51.2.106 · Cited by 170
Gender and cross-cultural differences in somatic symptoms associated with emotional distress. An international study in primary care
Piccinelli, M. P., & Simon, G. E. (1997) · Psychological Medicine · doi:10.1017/s0033291796004539 · Cited by 148

Show all 24 references

Research works printed but not linked: 5

Weir DC, Freeman W, Roberts KT, et al. Comparison of the measure of quality of life in patients with cystic fibrosis (CF) and chronic airflow obstruction (CAO). Thorax 1991;46:288.
Abbott J, Dodd M, Webb AK. Coping styles and treatment adherence in adults with cystic fibrosis. 21st European Cystic Fibrosis Conference, Davos, Switzerland, 1997.
Brazier JE, Harper R, Jones NMB, et al. Validating the SF36 health survey questionnaire: new outcome measure for pri- mary care. BMJ 1992;305:160-4.
Jenkinson C, Wright L, Coulter A. Quality of life measurement in health care. A review of measures and population norms for the UK SF-36. Health Services Research Unit, 1993.
Mechanic D. Sex, illness, illness behaviour and the use of health services. Soc Sci Med 1978;128:207-14.

Sorted by citations

Items 101–200 of 270

Coping styles in adults with cystic fibrosis: implications for emotional and social quality of life
Hugh, R. M., McFeeters, D., Boyda, D., & O’Neill, S. M. (2015) · Psychology Health & Medicine · doi:10.1080/13548506.2015.1020317 · Cited by 23
Validity and Reliability of the St George's Respiratory Questionnaire in Adults With Cystic Fibrosis
Galo, A. P., Olveira, G., Olveira, C., Dorado, A., Plata, A., Gaspar, I., & Frías, J. P. (2007) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(07)60052-4 · Cited by 23
A Randomized Controlled Trial of a New Behavioral Home-Based Nutrition Education Program, “Eat Well with CF,” in Adults with Cystic Fibrosis
Watson, H., Bilton, D., & Truby, H. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.02.017 · Cited by 22
Calidad de vida relacionada con la salud: conocer e implementar en la toma de decisiones basada en pruebas en pediatría
de Dios, J. G. (2004) · Anales de Pediatría · doi:10.1016/s1695-4033(04)78319-8 · Cited by 22
Validation of the Italian version of the Cystic Fibrosis Quality of Life Questionnaire (CFQoL), a disease specific measure for adults and adolescents with cystic fibrosis
Monti, F., Lupi, F., Gobbi, F., Agostini, F., Miano, A., Gee, L., & Abbott, J. (2007) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2007.06.003 · Cited by 22
Validez y fiabilidad del Cuestionario Respiratorio de St. George en población adulta con fibrosis quística
Galo, A. P., Olveira, G., Olveira, C., Dorado, A., Plata, A., Gaspar, I., & Frías, J. P. (2007) · Archivos de Bronconeumología · doi:10.1157/13100539 · Cited by 22
The measurement properties of tests and tools used in cystic fibrosis studies: a systematic review
McLeod, C., Wood, J., Tong, A., Schultz, A., Norman, R., Smith, S. J., Blyth, C. C., Webb, S. A. R., Smyth, A. R., & Snelling, T. (2021) · European Respiratory Review · doi:10.1183/16000617.0354-2020 · Cited by 23
Recombinant growth hormone therapy for cystic fibrosis in children and young adults
Thaker, V., Haagensen, A. L., Carter, B., Fedorowicz, Z., & Houston, B. W. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008901.pub2 · Cited by 22
Social support and social isolation in adults with cystic fibrosis: An integrative review
Gulledge, A., Miller, S., & Mueller, M. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110607 · Cited by 21
Interventions for promoting participation in shared decision-making for children and adolescents with cystic fibrosis
Malone, H., Biggar, S., Javadpour, S., Edworthy, Z., Sheaf, G., & Coyne, I. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012578 · Cited by 21
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
Lo, D. K. H., Muhlebach, M. S., & Smyth, A. R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009650.pub4 · Cited by 20
Vitamin K supplementation for cystic fibrosis
Jagannath, V. A., Fedorowicz, Z., Thaker, V., & Chang, A. B. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008482.pub3 · Cited by 21
Exploring Associations Between Self-Compassion, Self-Criticism, Mental Health, and Quality of Life in Adults with Cystic Fibrosis: Informing Future Interventions
Kauser, S., Keyte, R., Regan, A., Nash, E. F., Fitch, G., Mantzios, M., & Egan, H. H. (2021) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-021-09831-y · Cited by 28
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis
Jain, K., Wainwright, C. E., & Smyth, A. R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009530.pub2 · Cited by 20
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis
Waters, V. J., & Ratjen, F. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009528.pub3 · Cited by 20
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis
Smith, S. J., Rowbotham, N. J., & Charbek, E. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008319.pub4 · Cited by 19
A systematic review of patient-reported outcome measures (PROMs) in cystic fibrosis
Ratnayake, I., Ahern, S., & Ruseckaite, R. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033867 · Cited by 19
Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis
Amin, R., & Waters, V. J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009249.pub4 · Cited by 19
Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis
Ng, C., Major, G., & Smyth, A. R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013488.pub2 · Cited by 19
Vitamin E supplementation in people with cystic fibrosis
Okebukola, P. O., Kansra, S., & Barrett, J. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009422.pub4 · Cited by 19
How a clinical psychologist manages the problems of adults with cystic fibrosis.
Oxley, H., & Webb, A. K. (2005) · PubMed Central · Cited by 19
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis
Waters, V. J., & Ratjen, F. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009528.pub2 · Cited by 19
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis
Jain, K., Wainwright, C. E., & Smyth, A. R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009530.pub4 · Cited by 18
Vitamin K supplementation for cystic fibrosis
Jagannath, V. A., Fedorowicz, Z., Thaker, V., & Chang, A. B. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008482.pub4 · Cited by 17
Eating Disorders and Disordered Eating Behaviors in Cystic Fibrosis: A Neglected Issue
Petropoulou, A., Bakounaki, G., Grammatikopoulou, M. G., Bogdanos, D. P., Goulis, D. G., & Vassilakou, T. (2022) · Children · doi:10.3390/children9060915 · Cited by 21
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
Waters, V. J., & Ratjen, F. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010004.pub4 · Cited by 17
The impact of nocturnal oxygen desaturation on quality of life in cystic fibrosis
Young, A. C., Wilson, J. W., Kotsimbos, T. C., & Naughton, M. T. (2010) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2010.11.001 · Cited by 17
Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis
Palser, S. C., Smith, S. J., Nash, E. F., Agarwal, A., & Smyth, A. R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012300.pub2 · Cited by 17
Breathlessness catastrophizing relates to poorer quality of life in adults with cystic fibrosis
Maras, D., Balfour, L., Tasca, G. A., Gaudet, E., Aaron, S. D., Cameron, D. W., & Pakhale, S. S. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.08.008 · Cited by 16
Quality of Life in Paediatric Gastrointestinal and Liver Disease: A Systematic Review
Maity, S., & Thomas, A. G. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3180332df0 · Cited by 16
Polska adaptacja Kwestionariusza Jakości Życia przeznaczonego dla dzieci i dorosłych chorych na mukowiscydozę oraz ich rodziców (CFQ-R)
Sands, D., & Borawska-Kowalczyk, U. (2009) · Pediatria Polska · doi:10.1016/s0031-3939(09)70151-9 · Cited by 15
Assessing the Liverpool Respiratory Symptom Questionnaire in children with cystic fibrosis
Trinick, R. E., Southern, K. W., & McNamara, P. S. (2011) · European Respiratory Journal · doi:10.1183/09031936.00070311 · Cited by 15
Adherence to Physiotherapy and Quality of Life for Adults and Adolescents with Cystic Fibrosis
Ireland, C. (2003) · Physiotherapy · doi:10.1016/s0031-9406(05)60073-9 · Cited by 15
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
Waters, V. J., & Ratjen, F. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010004.pub2 · Cited by 15
Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis
Regan, K., & Bhatt, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009876.pub2 · Cited by 15
Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis
Dawson, S., Girling, C.-J., Cowap, L., & Clark-Carter, D. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013766.pub2 · Cited by 14
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
Lo, D. K. H., Muhlebach, M. S., & Smyth, A. R. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009650.pub5 · Cited by 15
Integrating Patient-Reported Outcomes Into Research and Clinical Practice
Quittner, A. L., Nicolais, C. J., & Saez-Flores, E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44887-1.00013-4 · Cited by 15
Pneumococcal vaccines for cystic fibrosis
Burgess, L., & Southern, K. W. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008865.pub4 · Cited by 14
Patient indicators of a pulmonary exacerbation: Preliminary reports from school aged children map onto those of adults
Abbott, J., Holt, A., Morton, A. M., Hart, A., Milne, G., Wolfe, S., & Conway, S. P. (2011) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2011.11.005 · Cited by 14
Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis
Smith, S. J., Calthorpe, R. J., Herbert, S., & Smyth, A. R. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013733.pub2 · Cited by 11
Young people with cystic fibrosis' concerns for their future: When and how should concerns be addressed, and by whom?
Iles, N., & Lowton, K. (2008) · Journal of Interprofessional Care · doi:10.1080/13561820801950325 · Cited by 13
Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis
Saldanha, I. J., Akinyede, O., & Robinson, K. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009421.pub3 · Cited by 13
Health-Related Quality of Life Instruments for Adolescents with Chronic Diseases
Quittner, A. L., Cruz, I., Modi, A. C., & Marciel, K. K. (2009) · Springer eBooks · doi:10.1007/978-0-387-87687-0_23 · Cited by 12
Validity of the DISABKIDS® - Cystic Fibrosis Module for Brazilian children and adolescents
Santos, D., Deon, K. C., Bullinger, M., & dos Santos, C. B. (2014) · Revista Latino-Americana de Enfermagem · doi:10.1590/0104-1169.3450.2485 · Cited by 13
Management of Cystic Fibrosis during COVID-19: Patient Reported Outcomes based remote follow-up among CF patients in Denmark – A feasibility study
Rodkjær, L. Ø., Jeppesen, M., & Schougaard, L. M. V. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.10.010 · Cited by 13
Indicators of pulmonary exacerbation in cystic fibrosis: A Delphi survey of patients and health professionals
McCourt, F., O'Neill, B. M., Logan, I., Abbott, J., Plant, B. J., McCrum-Gardner, E., McKEOWN, S. R., Elborn, J. S., & Bradley, J. M. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.06.007 · Cited by 13
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
Waters, V. J., & Ratjen, F. A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010004.pub3 · Cited by 13
Exercise versus airway clearance techniques for people with cystic fibrosis
Patterson, K., Walsh, A., McCormack, P., & Southern, K. W. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013285 · Cited by 12
Exploring the nature of perceived treatment burden: a study to compare treatment burden measures in adults with cystic fibrosis
Altabee, R., Carr, S. B., Abbott, J., Cameron, R. A., Daniel Office, Matthews, J., Simmonds, N. J., Cosgriff, R., Turner, D., & Whitty, J. A. (2022) · NIHR Open Research · doi:10.3310/nihropenres.13260.1 · Cited by 12
Health-related quality of life following lung transplantation for cystic fibrosis: A systematic review
Raguragavan, A., Jayabalan, D., & Saxena, A. (2023) · Clinics · doi:10.1016/j.clinsp.2023.100182 · Cited by 12
The Cystic Fibrosis Impact Questionnaire: qualitative development and cognitive evaluation of a new patient-reported outcome instrument to assess the life impacts of cystic fibrosis
McCarrier, K. P., Hassan, M., Hodgkins, P., Suthoff, E. D., McGarry, L. J., & Martin, M. L. (2020) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-020-00199-5 · Cited by 12
Recombinant growth hormone therapy for cystic fibrosis in children and young adults
Thaker, V., Carter, B., & Putman, M. S. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008901.pub4 · Cited by 13
Vitamin K supplementation for cystic fibrosis
Jagannath, V. A., Thaker, V., Chang, A. B., & Price, A. I. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008482.pub6 · Cited by 12
Life-space mobility is associated with frequency of hospitalization in adults with cystic fibrosis
Gottlieb, E. R., Smith, E., Wolfenden, L. L., Allman, R. M., & Tangpricha, V. (2010) · The Clinical Respiratory Journal · doi:10.1111/j.1752-699x.2010.00225.x · Cited by 12
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
Waters, V. J., & Ratjen, F. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010004 · Cited by 12
Short-acting inhaled bronchodilators for cystic fibrosis
Smith, S. J., Rowbotham, N. J., & Edwards, C. T. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013666.pub2 · Cited by 11
Oral anti-pseudomonal antibiotics for cystic fibrosis
Remmington, T., Jahnke, N., & Harkensee, C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005405.pub2 · Cited by 11
Digital technology for early identification of exacerbations in people with cystic fibrosis
Wong, C.-H., Smith, S. J., & Kansra, S. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014606.pub2 · Cited by 8
Factors related to changes in the quality of life among Polish adolescents and adults with cystic fibrosis over a 1-year period
Dębska, G., & Mazurek, H. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s88385 · Cited by 10
Physical performance, quality of life and sexual satisfaction evaluation in adults with cystic fibrosis: An unexplored correlation
Aguiar, K. C. A., Marson, F. A. L., Gomez, C. C. S., Pereira, M. C., Paschoal, I. A., Ribeiro, A. F., & Ribeiro, J. D. (2017) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppnen.2017.02.009 · Cited by 10
Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis
Palser, S. C., Nash, E. F., Agarwal, A., & Smyth, A. R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012300 · Cited by 10
The effects of cystic fibrosis on couples: Marital satisfaction, emotions, and coping strategies
Delelis, G., Christophe, V., Leroy, S., Vanneste, J., & Wallaert, B. (2008) · Scandinavian Journal of Psychology · doi:10.1111/j.1467-9450.2008.00683.x · Cited by 10
Vitamin K supplementation for cystic fibrosis
Jagannath, V. A., Fedorowicz, Z., Thaker, V., & Chang, A. B. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008482.pub2 · Cited by 10
Vitamin E supplementation in people with cystic fibrosis
Okebukola, P. O., Kansra, S., & Barrett, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009422.pub2 · Cited by 10
A novel respiratory symptom scoring system for CF pulmonary exacerbations
Jarad, N. A., & Sequeiros, I. (2011) · QJM · doi:10.1093/qjmed/hcr149 · Cited by 9
Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis
Saldanha, I. J., Akinyede, O., & Robinson, K. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009421.pub4 · Cited by 9
The Experience of Receiving a Diagnosis of Cystic Fibrosis After Age 20
Widerman, E. (2004) · Social Work in Health Care · doi:10.1300/j010v39n03_12 · Cited by 9
Higher Mobility Scores in Patients with Cystic Fibrosis Are Associated with Better Lung Function
Thobani, A., Alvarez, J. A., Blair, S., Jackson, K., Gottlieb, E. R., Walker, S., & Tangpricha, V. (2015) · Pulmonary Medicine · doi:10.1155/2015/423219 · Cited by 9
Do Patient-Reported Outcomes Have a Role in the Management of Patients with Cystic Fibrosis?
Salek, S., Jones, S., Rezaie, M. S., Davies, C., Mills, R., & Ketchell, R. I. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00038 · Cited by 9
Quality of life in patients with cystic fibrosis depending on the severity of the disease and method of its treatment
Dębska, G., Cepuch, G., & Mazurek, H. (2014) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1101598 · Cited by 9
Quality of Life in Adults with Cystic Fibrosis: The Greek Experience
Stofa, M., Xanthos, T. T., Ekmektzoglou, K. A., Chalkias, A. F., Barouxis, D., Pantazopoulos, I. N., & Iacovidou, N. M. (2016) · Advances in respiratory medicine · doi:10.5603/piap.2016.0025 · Cited by 9
Vitamin K supplementation for cystic fibrosis
Jagannath, V. A., Thaker, V., Chang, A. B., & Price, A. I. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008482.pub5 · Cited by 9
Physical Activity and Sedentary Behavior in Adults With Cystic Fibrosis: Association With Aerobic Capacity, Lung Function, Sleep, Well-Being, and Quality of Life
Curran, M., Tierney, A. C., Button, B., Collins, L., Kennedy, L., McDonnell, C., Sheikhi, A., Jurascheck, A. J., Casserly, B. P., & Cahalan, R. (2021) · Respiratory Care · doi:10.4187/respcare.09270 · Cited by 8
Nebuliser systems for drug delivery in cystic fibrosis
Stanford, G. E., Morrison, L., & Brown, C. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007639.pub3 · Cited by 11
Interventions for the eradication of methicillin-resistantStaphylococcus aureus(MRSA) in people with cystic fibrosis
Lo, D. K. H., Hurley, M. N., Muhlebach, M. S., & Smyth, A. R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009650.pub2 · Cited by 21
Antibiotic treatment forStenotrophomonas maltophiliain people with cystic fibrosis
Amin, R., & Waters, V. J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009249.pub2 · Cited by 8
Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis
Saldanha, I. J., Akinyede, O., & Robinson, K. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009421.pub2 · Cited by 8
Measurement of treatment burden in cystic fibrosis: A systematic review
Altabee, R., Mwamba, M. J., Turner, D., Davies, G., Abbott, J., Simmonds, N. J., Whitty, J. A., Carr, S. B., Barton, G., & Cameron, R. A. (2024) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2024.11.005 · Cited by 7
Part 2: The feasibility of utilising photovoice method and the World Health Organization Quality of Life instrument in evaluating the Community-Based Rehabilitation programme in Namibia: A pilot study
Shumba, T. W., & Moodley, I. (2018) · African Journal of Disability · doi:10.4102/ajod.v7i0.419 · Cited by 7
Steps Ahead: optimising physical activity and health in people with cystic fibrosis: Study Protocol for a pilot randomised trial
Curran, M., Tierney, A. C., Collins, L., Kennedy, L., McDonnell, C., Jurascheck, A. J., Sheikhi, A., Walsh, C., Button, B., Galvin, R., et al. (2020) · HRB Open Research · doi:10.12688/hrbopenres.13025.1 · Cited by 6
Patient-Reported Outcome Measures for Symptom Perception During a Cystic Fibrosis Exacerbation
Schmid‐Mohler, G., Caress, A., Spirig, R., Benden, C., & Yorke, J. (2018) · Respiratory Care · doi:10.4187/respcare.05638 · Cited by 7
Validación de la versión en español del Cuestionario de Tos Leicester en niños con fibrosis quística
del Corral, T., Percegona, J., López, N., Valiente, A., Garriga, M. J., Seborga, M., & Vilaró, J. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2015.01.016 · Cited by 7
Pneumococcal vaccines for cystic fibrosis
Burgess, L., & Southern, K. W. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008865.pub2 · Cited by 7
Functional Measures in Non-COPD Chronic Respiratory Diseases: A Systematic Review
Zamboti, C. L., Pimpão, H. A., Bertin, L. D., Krinski, G. G., Garcia, T., Filho, S. L. S. D. S., Cavalheri, V., Pitta, F. D. O., & Camillo, C. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226887 · Cited by 7
Steps Ahead: optimising physical activity in adults with cystic fibrosis: Study Protocol for a pilot randomised trial using wearable technology, goal setting and text message feedback.
Curran, M., Tierney, A. C., Collins, L., Kennedy, L., McDonnell, C., Jurascheck, A. J., Sheikhi, A., Walsh, C., Button, B., Galvin, R., et al. (2020) · HRB Open Research · doi:10.12688/hrbopenres.13025.3 · Cited by 6
Health related quality of life in Indian children with cystic fibrosis
Kir, D., Gupta, S. D., Jolly, G., Kalaivani, M., Lodha, R., & Kabra, S. K. (2015) · Indian Pediatrics · doi:10.1007/s13312-015-0645-7 · Cited by 6
Percepção de qualidade de vida de pessoas com fibrose cística: um estudo sobre a adequação dos instrumentos de medida
Bredemeier, J., & Gomes, W. B. (2007) · Revista de Psiquiatria do Rio Grande do Sul · doi:10.1590/s0101-81082007000100010 · Cited by 6
Oral anti-pseudomonal antibiotics for cystic fibrosis
Remmington, T., Jahnke, N., & Harkensee, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005405.pub3 · Cited by 6
Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis
Amin, R., & Waters, V. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009249.pub3 · Cited by 6
Vitamin E supplementation in people with cystic fibrosis
Okebukola, P. O., Kansra, S., & McCabe, H. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009422 · Cited by 6
Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis
Beer, H., Southern, K. W., & Swift, A. C. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008253.pub2 · Cited by 6
Development and validation of a short form psychometric tool assessing the caregiving Challenge of Living with Cystic Fibrosis (CLCF-SF) in a child
McCray, G., Hope, H. F., Glasscoe, C., Hill, J., Quittner, A. L., Southern, K. W., & Lancaster, G. (2023) · Psychology and Health · doi:10.1080/08870446.2023.2231489 · Cited by 5
Dosing regimens for pancreatic enzyme replacement therapy (PERT) in cystic fibrosis
Ng, C., Major, G., & Smyth, A. R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013488 · Cited by 5
Herramientas de evaluación de calidad de vida y tolerancia al ejercicio en niños y adolescentes con fibrosis quística: revisión sistemática
Blanco‐Orive, P., del Corral, T., Martín‐Casas, P., Ceniza-Bordallo, G., & López‐de‐Uralde‐Villanueva, I. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2021.06.025 · Cited by 5
Recombinant growth hormone therapy for cystic fibrosis in children and young adults
Thaker, V., Carter, B., & Putman, M. S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008901.pub5 · Cited by 5
Pneumococcal vaccines for cystic fibrosis
Burgess, L., & Southern, K. W. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008865.pub3 · Cited by 5
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis
Waters, V. J., & Ratjen, F. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009528 · Cited by 5
Eradication therapy forBurkholderia cepaciacomplex in people with cystic fibrosis
Regan, K., & Bhatt, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009876 · Cited by 5
The equitable challenges to quality use of modulators for cystic fibrosis in Australia
Fawcett, L. K., Waters, S. A., & Jaffé, A. (2024) · The Medical Journal of Australia · doi:10.5694/mja2.52527 · Cited by 3

Authors: Gee, L.
Affiliations: University of Lancashire (GB)
Corresponding author: Gee, L
Venue: Thorax
Publisher: BMJ
Published: 2000-11-01
Volume: 55
Issue: 11
Pages: 946-954
ISSN: 0040-6376 (ISSN-L)
DOI: 10.1136/thorax.55.11.946
PMC: PMC1745639
OpenAlex: W2142930532
Cited by: 272
References: 24
Citations by year: 2026: 3 · 2025: 8 · 2024: 7 · 2023: 8 · 2022: 10 · 2021: 12 · 2020: 14 · 2019: 9 · 2018: 13 · 2017: 9 · 2016: 12 · 2015: 18 · 2014: 16 · 2013: 10 · 2012: 16
FWCI: 4.78
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Thorax (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
Health Sciences › Nursing › Research and Theory › Health Education and Validation
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords: cystic fibrosis, health-related quality of life, disease-specific questionnaire, questionnaire development, questionnaire validation, adolescents, adults, test-retest reliability, sensitivity to change, concurrent validity, item generation
MeSH terms: Adolescent, Adult, Cystic Fibrosis, Female, Health Status, Humans, Life Style, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Sensitivity and Specificity, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks